Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.
about
MIPs and Aptamers for Recognition of Proteins in Biomimetic Sensing.Diagnostic technologies for circulating tumour cells and exosomes.A survey of computational tools for downstream analysis of proteomic and other omic datasetsAptamer Microarrays-Current Status and Future ProspectsCarcinogenic activity of PbS quantum dots screened using exosomal biomarkers secreted from HEK293 cellsNano-plasmonic exosome diagnosticsNew Technologies Provide Quantum Changes in the Scale, Speed, and Success of SELEX Methods and Aptamer Characterization.Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblastsNucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsPlasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach.Characterisation of adipocyte-derived extracellular vesicles released pre- and post-adipogenesis.Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndromeProteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells.Coupling enrichment methods with proteomics for understanding and treating disease.Trends in aptamer selection methods and applications.Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.Emerging Proteomic Technologies Provide Enormous and Underutilized Potential for Brain Cancer Research.The contribution of tumour-derived exosomes to the hallmarks of cancer.The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study.Protein arrays for biomarker discovery in lupus.Ready-made chromatography columns for extracellular vesicle isolation from plasmaMission Critical: The Need for Proteomics in the Era of Next-Generation Sequencing and Precision Medicine.Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis.Proteomic insights into extracellular vesicle biology - defining exosomes and shed microvesicles.Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes.Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes.Exosomes in diagnosis and therapy of prostate cancer.Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis.Bariatric Surgery Is Accompanied by Changes in Extracellular Vesicle-Associated and Plasma Fatty Acid Binding Protein 4.Aptamer/AuNP Biosensor for Colorimetric Profiling of Exosomal Proteins.Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology.Stability and reproducibility of proteomic profiles measured with an aptamer-based platform.Simple Methods and Rational Design for Enhancing Aptamer Sensitivity and Specificity.
P2860
Q26738688-6E54FFD7-F8E1-4A90-BAEA-BE54380FC26BQ26776003-70469816-A18A-4DA8-BF9C-BA0711535E8FQ26778173-CB7C1055-455E-4DB0-A67D-46BAC24F74D5Q28083114-AE44B108-0802-4586-AD58-AF705F60A5D9Q28387827-D4592BB5-4C91-4A2B-A295-BC0FD9FCE0D0Q30396400-5AFD57C6-55F8-447D-90F7-F08486364337Q34459376-6C5E771C-2F2F-4449-A1CE-C3720F683BC1Q35176121-DFBA8A7D-3331-47AB-BFBC-D46CDBE2185FQ35309726-3D655994-0AF9-4B99-9226-74917CE2CFCAQ36285320-FA0C31FE-9B3B-408C-B0A3-1F9CA9D31291Q36322259-B865DD9C-C1F8-4BE0-8B4D-E223F5F500F5Q36903959-BBACF327-F97F-4C2A-B1A3-A86500E25B78Q37057070-4FBD0E29-0F55-4BE7-82B1-1C1E1914F16BQ37097040-2D49D1AD-9842-4890-824F-25094CB6C638Q38293824-4D829DAE-CE54-43B4-A57B-18D71FB631A3Q38298067-7EE0276E-DD33-401B-91C1-EBCF5065526FQ38367417-8F9DF799-421D-4F7E-B865-381B3AD75E2FQ38436237-A68D45BF-FD5C-4252-AD19-E13E8844E071Q38443249-0245E1CE-C77D-4FAF-B27D-2F3DC6150341Q38547265-8DEDAF8C-FC01-4BF7-A5A6-0EB8E2853EFAQ38593065-4B859A5E-E8D8-4065-8137-8B8E95B3B489Q38610872-1D6E59D3-AD30-4D28-8AD6-C6034E6A022FQ38664824-039B4718-9188-420F-B377-EC6001212BB9Q38673773-582855C4-0D6F-43F2-8632-273D81B0E4A4Q38893686-CBCC481C-3703-4EF7-A684-2631DDCFDB8CQ38903529-AF91F5F5-1FE6-4093-810A-BE530898A53AQ38912741-E0E86869-2073-4ACC-A9B5-A6A7CE0FE3AEQ39006827-15B4D3CC-7940-4C2A-A5EF-DE863240F5F7Q39218490-68D2079E-0A62-446D-95B9-AF0893DFA13AQ41535142-455EA202-7FD5-4A30-881F-B6B389868455Q41675007-5ADBE93E-B2FB-4A49-8224-C601DE39D87FQ41675016-30D7A00A-6F34-4BC6-951A-C46308E41A25Q47117604-A843CD03-17CD-4149-8D59-0D633490DC3AQ47400242-1CED6B41-7E8D-4BD1-BCE3-B98FA1C5FDF3Q47642599-F2CB6D07-AA3E-4D19-981C-40C1F3281591Q47763068-508F9493-FD3E-4ADF-9F7A-DF327605FEB2Q48156075-8439B9BC-DA57-4B84-86FA-213C94ABC46EQ48313209-68C8F02C-4F06-4FB3-A974-537C5A1FAE88Q55178512-C19A2ADE-D76F-4AAD-B61C-A6C22FB7F986Q55287229-60A1A8B6-200C-4EBF-BD71-5FB120F8BEE0
P2860
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomics analysis of cancer ...... ed array (SOMAscan™) platform.
@en
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array
@nl
type
label
Proteomics analysis of cancer ...... ed array (SOMAscan™) platform.
@en
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array
@nl
prefLabel
Proteomics analysis of cancer ...... ed array (SOMAscan™) platform.
@en
Proteomics analysis of cancer exosomes using a novel modified aptamer-based array
@nl
P2093
P2860
P50
P356
P1476
Proteomics analysis of cancer ...... sed array (SOMAscan™) platform
@en
P2093
Breanna C Smith
Bridget Gordon
Evaldas Katilius
Ian A Brewis
Malcolm D Mason
Timothy C Stone
P2860
P304
P356
10.1074/MCP.M113.032136
P577
2014-02-06T00:00:00Z